Read up on studies
STAR trial: VeriSeq™ PGS
The STAR trial: A randomised controlled trial (RCT) comparing pregnancy rates following VeriSeq™ PGS versus standard morphology for elective single embryo transfer (eSET).Read scientific summary
Development and validation of a next-generation sequencing–based protocol for 24-chromosome aneuploidy screening of embryos
Fiorentino et al., (2014) performed a validation of the VeriSeq PGS Solution to investigate its applicability to PGT-A. Karyotypically defined chromosomally abnormal single cells and whole-genome amplified products, previously analysed by array-CGH, selected from 68 clinical PGT-A cycles with embryos biopsied at cleavage stage. NGS specificity for aneuploid embryo call was 100% with a sensitivity of 100%. Fiorentino concluded that this product demonstrated a robust methodology ready for clinical applications in reproductive medicine, which potential advantages of reduced costs and enhanced precision.Read study
Increase my knowledge
Webinar: 'Genomics in Assisted Reproduction'
The use of genomics has the potential to further transform assisted reproduction. In this recorded webinar we discuss the latest technologies that have potential applications in IVF. Listen to our expert speakers who will share their experience of current and future trends.Watch webinar
Webinar: 'Current and Future Trends in PGT-A'
In this recorded webinar, we will get insights from experts in the field of PGT-A in assisted reproduction. Our presenters will share retrospective data from PGT-A in highly successful programs, synergistic technologies to improve outcomes, and the future applications currently being investigated in research programs.Watch webinar
Webinar: 'Utilising Genomics in IVF: From Carrier Screening to Karyomapping'
The use of genomics in assisted reproduction has transformed IVF around the world. In this recorded webinar, you will join us for a rediscovery of Karyomapping PGT-M technology, including the ability to solve challenging cases, and an overview of the pivotal role of the clinician and genetic counsellor.Watch webinar
Webinar: 'PGT-M; Karyomapping uncovered'
In this recorded version, you will join us for a rediscovery of Karyomapping PGT-M technology, including challenging cases solved and the concurrent detection of aneuploidies. Gain an understanding of the journey from a genetic counsellor’s perspective and discover the benefits of the comprehensive PGT-M solution.Watch webinar
Webinar:'Current and future trends in PGT-A - incorporating PGT-A into the IVF journey'
In this recorded webinar, Prof Alan Handyside reviews evidence for the effectiveness of PGT-A as an additional tool for embryo selection to improve clinical outcomes, particularly for single embryo transfers. Prof Handyside also considers how to implement PGT-A successfully and reviews prospects for non-invasive testing for aneuploidy (niPGT-A) using spent culture medium.Watch webinar
Using PGS and time-lapse in synergy will enhance your decision making
Picking out the embryo(s) most likely to be viable is the goal of any embryo selection process. Both time-lapse and preimplantation genetic screening (PGS) are well established methods for enhancing the chance of transferring a viable embryo. This blog post describes how using them together can enhance your decision making.Read blog post
Considerations when introducing PGS in your IVF clinic
PGS aims to detect numerical and/or structural chromosomal disorders of the developing embryo. This white paper will guide you through the most important topics to consider when introducing PGS in your IVF laboratory.Download white paper
Time-lapse technology in a PGS world – is there room for both?
Time-lapse and PGS are two ways of selecting embryos for transfer and cryopreservation. In this presentation from ESHRE 2016, Prof. Simon Fishel from CARE Fertility will present how these methods can complement each other.